SLC9A1 and breast cancer: In regions of hypoxia, however, NHE1 activity is reduced [46] and NHE1 gene expression is reported to be low in basal type and triple negative breast cancers [47], whereas CAIX is expressed in over 50% of patients with this breast cancer subtype [15], a patient subset that also expresses MMP-14.